Hitoshi Maeshima

996 total citations
35 papers, 806 citations indexed

About

Hitoshi Maeshima is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Biochemistry. According to data from OpenAlex, Hitoshi Maeshima has authored 35 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biological Psychiatry, 12 papers in Psychiatry and Mental health and 10 papers in Biochemistry. Recurrent topics in Hitoshi Maeshima's work include Tryptophan and brain disorders (14 papers), Amino Acid Enzymes and Metabolism (10 papers) and Alzheimer's disease research and treatments (9 papers). Hitoshi Maeshima is often cited by papers focused on Tryptophan and brain disorders (14 papers), Amino Acid Enzymes and Metabolism (10 papers) and Alzheimer's disease research and treatments (9 papers). Hitoshi Maeshima collaborates with scholars based in Japan and United States. Hitoshi Maeshima's co-authors include Heii Arai, Toshihito Suzuki, Hajime Baba, Yoshiyuki Nakano, Tohru Ohnuma, Nobuto Shibata, Yoshie Sakai, Masaru Mimura, Megumi Inoue and Hiroshi Nomoto and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Bulletin and Psychiatry Research.

In The Last Decade

Hitoshi Maeshima

34 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Maeshima Japan 20 262 240 158 148 134 35 806
Alessandra Solida Switzerland 11 281 1.1× 277 1.2× 88 0.6× 128 0.9× 119 0.9× 32 854
Sylvain Grignon Canada 18 167 0.6× 454 1.9× 202 1.3× 106 0.7× 176 1.3× 45 989
Abigail J. Sheldrick Germany 19 304 1.2× 212 0.9× 95 0.6× 161 1.1× 206 1.5× 32 918
Denise R. Evans United States 12 327 1.2× 490 2.0× 186 1.2× 223 1.5× 108 0.8× 15 1.3k
Mariana Pedrini Brazil 16 334 1.3× 336 1.4× 122 0.8× 180 1.2× 81 0.6× 29 783
Oussama Kébir France 19 151 0.6× 396 1.6× 72 0.5× 217 1.5× 231 1.7× 60 1.0k
Murray Anderson‐Hunt Australia 12 665 2.5× 644 2.7× 105 0.7× 141 1.0× 82 0.6× 14 1.3k
Ryosuke Tarumi Japan 14 357 1.4× 232 1.0× 97 0.6× 107 0.7× 310 2.3× 32 948
Hideaki Mitani Japan 14 209 0.8× 106 0.4× 137 0.9× 135 0.9× 271 2.0× 18 856
Chih‐Chiang Chiu Taiwan 13 148 0.6× 312 1.3× 91 0.6× 126 0.9× 64 0.5× 41 734

Countries citing papers authored by Hitoshi Maeshima

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Maeshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Maeshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Maeshima more than expected).

Fields of papers citing papers by Hitoshi Maeshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Maeshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Maeshima. The network helps show where Hitoshi Maeshima may publish in the future.

Co-authorship network of co-authors of Hitoshi Maeshima

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Maeshima. A scholar is included among the top collaborators of Hitoshi Maeshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Maeshima. Hitoshi Maeshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maeshima, Hitoshi, et al.. (2021). Apolipoprotein E4 increases the risk of depression recurrence. Journal of Affective Disorders. 295. 628–631. 5 indexed citations
2.
Baba, Hajime, et al.. (2018). Increased Serum Levels of α-Synuclein in Patients With Major Depressive Disorder. American Journal of Geriatric Psychiatry. 27(3). 280–286. 21 indexed citations
3.
Baba, Hajime, et al.. (2017). Glucocorticoid may influence amyloid β metabolism in patients with depression. Psychiatry Research. 259. 191–196. 22 indexed citations
4.
Maeshima, Hitoshi, et al.. (2016). Residual Memory Impairment in Remitted Depression May Be a Predictive Factor for Recurrence. The Journal of Clinical Psychiatry. 77(2). 247–251. 12 indexed citations
5.
Nomoto, Hiroshi, et al.. (2015). Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression. BMC Psychiatry. 15(1). 33–33. 15 indexed citations
6.
Ohnuma, Tohru, Masayoshi Takeuchi, Hitoshi Maeshima, et al.. (2015). Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia. Neuroscience Letters. 593. 51–55. 19 indexed citations
7.
8.
9.
Maeshima, Hitoshi, et al.. (2014). Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching. Journal of Affective Disorders. 170. 185–189. 30 indexed citations
10.
Baba, Hajime, et al.. (2014). Temperament and character as predictors of recurrence in remitted patients with major depression: A 4-year prospective follow-up study. Psychiatry Research. 225(3). 322–325. 12 indexed citations
11.
Maeshima, Hitoshi, Hajime Baba, Yoshiyuki Nakano, et al.. (2013). Time course for memory dysfunction in early-life and late-life major depression: A longitudinal study from the Juntendo university mood disorder project. Journal of Affective Disorders. 151(1). 66–70. 14 indexed citations
12.
Maeshima, Hitoshi, Hirofumi Kurita, Yoshiyuki Nakano, et al.. (2013). Gender Differences in Serum Testosterone and Cortisol in Patients with Major Depressive Disorder Compared with Controls. The International Journal of Psychiatry in Medicine. 46(2). 203–221. 33 indexed citations
13.
Maeshima, Hitoshi, Hajime Baba, Yoshiyuki Nakano, et al.. (2012). DURATION OF LAST DEPRESSIVE EPISODE MAY INFLUENCE SERUM BDNF LEVELS IN REMITTED PATIENTS WITH MAJOR DEPRESSION. Depression and Anxiety. 29(9). 775–779. 14 indexed citations
14.
Kurita, Hirofumi, Hitoshi Maeshima, Yoshiyuki Nakano, et al.. (2012). Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Journal of Affective Disorders. 146(2). 205–212. 35 indexed citations
15.
Baba, Hajime, et al.. (2011). Metabolism of Amyloid-β Protein May Be Affected in Depression. The Journal of Clinical Psychiatry. 73(1). 115–120. 34 indexed citations
16.
Ohnuma, Tohru, et al.. (2011). No genetic association between SLC7A10 and Japanese patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(8). 1965–1968. 2 indexed citations
17.
Ohnuma, Tohru, Nobuto Shibata, Hitoshi Maeshima, et al.. (2011). Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(2). 636–639. 25 indexed citations
18.
Ohnuma, Tohru, et al.. (2009). Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(3). 511–518. 19 indexed citations
19.
Nakano, Yoshiyuki, Hajime Baba, Hitoshi Maeshima, et al.. (2008). Executive dysfunction in medicated, remitted state of major depression. Journal of Affective Disorders. 111(1). 46–51. 85 indexed citations
20.
Maeshima, Hitoshi, Tohru Ohnuma, Yoshie Sakai, et al.. (2007). Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia — Juntendo University Schizophrenia Projects (JUSP). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(7). 1410–1418. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Solida Breakdown of academic impact, for papers by Sylvain Grignon Breakdown of academic impact, for papers by Abigail J. Sheldrick Breakdown of academic impact, for papers by Denise R. Evans Breakdown of academic impact, for papers by Mariana Pedrini Breakdown of academic impact, for papers by Oussama Kébir Breakdown of academic impact, for papers by Murray Anderson‐Hunt Breakdown of academic impact, for papers by Ryosuke Tarumi Breakdown of academic impact, for papers by Hideaki Mitani Breakdown of academic impact, for papers by Chih‐Chiang Chiu
Rankless by CCL
2026